More Than USD 439.8 Million Revenues Projected to Be Accounted by U.S Bacterial Conjunctivitis Drugs Market by End of 2027
According to a new market report published by Persistence Market Research "The U.S Market Study on Bacterial Conjunctivitis Drugs: fluoroquinolones to be the Largest Segment by 2024" the bacterial conjunctivitis drugs market in the U.S. was valued at USD 473.3 million in 2013 and is estimated to reach a market worth of USD 439.8 million in 2024, at a CAGR of2.7%from 2012 to 2018 and (-3.73%) from 2018 to 2024.Conjunctivitis is an inflammation of the conjunctiva - the clear membrane...
View full press release